Law & Practice

INDIA: Delhi High Court Mandates Drug Controller General to Regulate Misuse of Identical Marks in Pharmaceuticals

Published: April 15, 2019

Mohan Dewan R K Dewan & Co. Mumbai, Maharashtra, India INTA Bulletins Committee - Asia-Pacific Subcommittee


Sushant Singh Supreme Court of India & Delhi High Court New Delhi, Delhi, India

This page is accessible solely to INTA members.

Log In     Join INTA

Free Trial Membership

Take advantage of a 21-day free trial membership to access exclusive member-only content. See details

*Required. By clicking “Request Trial Membership,” I agree to INTA’s Privacy Policy and website Terms of Use. No credit card or billing information required.